Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResApp Health.
RELATED STOCKHEAD STORIES
News
Weekly Small Cap and IPO Wrap: Analysts and August end ancient blood feud as markets continue to rise
Experts
ScoPo’s Powerplays: ‘Big haircuts’ for ASX health stocks – Morgans reviews quarterly results
News
Closing Bell: Mrs Pelosi goes to Taipei; Pfizer comes back for ResApp
News
ASX Small Caps Lunch Wrap: Who else is up to some serious monkey business today?
News
CRITERION: It’s a small cap smorgasboard with takeover targets on the table
Health & Biotech
ASX Health Stocks: FDA to expedite submission for Botanix’s sweaty armpits gel
Health & Biotech
ASX Health Stocks: ResApp gets FDA nod, while Japan grants Immutep a patent
Tech
Here’s ResApp’s CEO on what happens next, and the other ASX targets with live offers
Health & Biotech
ASX Health Stocks: Trajan rattles the tin in further $5 million cap raise
Health & Biotech
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX
Health & Biotech
Check Up: Samsung and Big Pharma give big thumbs up to biotech sector
Mining
Closing Bell: Small caps resurgent as silver mother-lode takes Ted to Tangoa, lifts LDR by 50pc
News
ASX Small Caps Lunch Wrap: Who else has been seduced by a Swedish bin this morning?
Health & Biotech
ASX Health Stocks: ResApp’s COVID-conscious smartphone tool fails new test, shares crash 30pc
News
Top 10 at 10: The ASX stocks investors like (and dislike) the most in early trade Tuesday
Experts
ScoPo’s Powerplays: Business as usual for ASX health stocks plus… some good news!
Energy
